MedAdvisor Aktie

MedAdvisor EBITDA-margin

Delisted

EBITDA-margin for MedAdvisor (MDR.AX) pr. 10. aug. 2026 er -15,66 %. I foregående år var EBITDA-margin 3,13 % — en ændring på -599,67 % (lavere).

EBITDA-margin

-15,66 %

YoY

-599,67%

Senest opdateret:

EBITDA-margin for MedAdvisor er 2026 -15,66 % . EBITDA-margin for MedAdvisor var 2025 3,13 % . Det falder dermed med -599,67% lavere sammenlignet med året før.
Access this data via the Eulerpool API

MedAdvisor Aktieanalyse

Hvad laver MedAdvisor? Medadvisor Ltd is an Australian company that offers a digital platform for healthcare. Founded in 2012 by Robert Read, David Liu, and Josh Swinnerton, their aim was to develop a platform that simplifies medication management for patients, pharmacies, and doctors. Today, Medadvisor is a publicly traded company with a wide range of digital healthcare solutions. They offer various solutions to support patients in medication intake and management, such as a mobile application that allows patients to manage their medications, order prescriptions, and receive reminders. They also offer solutions for pharmacies, including an online ordering system and access to electronic patient history, as well as a platform for doctors to electronically issue prescriptions. One of their latest products is a mobile application that facilitates the handling of COVID-19, providing real-time virus spread tracking and symptom tracking tools. Medadvisor focuses on meeting customer needs and continuously improving the healthcare process. They recently partnered with Take2 Healthcare to expand their range of solutions and create the best offering of health solutions. Overall, Medadvisor plays an important role in the Australian healthcare system by helping their customers live happier and healthier lives through innovative technologies and services. MedAdvisor er et af de mest populære virksomheder på Eulerpool.com.

Hyppigt stillede spørgsmål om MedAdvisor aktie

EBITDA-margin for MedAdvisor er -15,66 % i 2026.

EBITDA-margin for MedAdvisor ændrede sig fra 3,13 % til -15,66 %, hvilket repræsenterer en ændring på -599,67 %. Værdien er lavere end i foregående år.

På Eulerpool kan du finde den fuldstændige historiske udvikling af EBITDA-margin MedAdvisor siden 2006 – med årlige værdier, diagrammer og detaljeret analyse.

EBITDA-marginen viser, hvilken procentdel af omsætningen der konverteres til EBITDA. Den normaliserer for af- og nedskrivninger og kapitalstrukturforskelle.

En 'god' varierer efter branche og virksomhedens udviklingsstadium. På Eulerpool kan du sammenligne EBITDA-margins MedAdvisor med konkurrenter og branchegjennemsnittet for at afgøre, om den er attraktiv.

For at evaluere EBITDA-margins er det afgørende at sammenligne det med andre virksomheder i samme branche og sektor. På Eulerpool kan du finde branchsammenligninger for EBITDA-margin.

Access this data via the Eulerpool API

Marginer — MedAdvisor

Alle nøgletal — MedAdvisor